During the past decade, Centro Hospitalar Tondela Viseu conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 2 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centro Hospitalar Tondela Viseu" #1 sponsor was "Janssen Research & Development, LLC" with 5 trials, followed by "Centro Hospitalar Tondela-Viseu" with 4 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Centro Hospitalar do Porto" with 1 trials sponsored and "Enrique de-Madaria" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Hospitalar Tondela Viseu" #1 collaborator was "Antonio Pipa, M.D." with 1 trials as a collaborator, "José Damasceno Costa, M.D." with 1 trials as a collaborator, "Marta Fernandes, M.D. MSc" with 1 trials as a collaborator, "Portuguese IBD Group" with 1 trials as a collaborator and "Raquel Oliveira, MSc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Centro Hospitalar Tondela Viseu" are "Crohn Disease" (2 trials), "Crohn's Disease" (2 trials), "Inflammatory Bowel Diseases" (2 trials), "Acute Pancreatitis" (1 trials) and "Coagulation Disorder" (1 trials). Many other conditions were trialed in "Centro Hospitalar Tondela Viseu" in a lesser frequency.

Most popular intervention types in "Centro Hospitalar Tondela Viseu" are "Drug" (7 trials), "Biological" (2 trials), "Behavioral" (1 trials), "Device" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Guselkumab" (4 trials), "Golimumab" (2 trials), "Guselkumab Dose 1" (2 trials) and "Guselkumab Dose 2" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centro Hospitalar Tondela Viseu" are 12 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Centro Hospitalar Tondela Viseu". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Centro Hospitalar Tondela Viseu, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centro Hospitalar Tondela Viseu, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".